(HealthDay News) — (Tasrir) — “As of June 17, 2024, a total of 26 illnesses have been reported from 16 states,” the FDA noted in an updated advisory. That’s up from 12 cases in 8 states reported a week ago.
“Twenty-five of the 26 people have reported seeking medical care; 16 have been hospitalized,” the FDA added, noting that “no deaths have been reported.”
The exact cause of the illnesses isn’t clear, but the FDA said its “investigation is ongoing to determine the cause of these illnesses and the appropriate next steps.”
Symptoms have included “seizures, central nervous system depression [loss of consciousness, confusion, sleepiness], agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting,” the agency added.
“As of June 17, 2024, a total of 26 illnesses have been reported from 16 states,” the FDA noted in an updated advisory. That’s up from 12 cases in 8 states reported a week ago.
“Twenty-five of the 26 people have reported seeking medical care; 16 have been hospitalized,” the FDA added, noting that “no deaths have been reported.”
The exact cause of the illnesses isn’t clear, but the FDA said its “investigation is ongoing to determine the cause of these illnesses and the appropriate next steps.”
Symptoms have included “seizures, central nervous system depression [loss of consciousness, confusion, sleepiness], agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting,” the agency added.
